These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11404516)

  • 1. Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen.
    Turner BJ; Zhang D; Laine C; Pomerantz RJ; Cosler L; Hauck WW
    J Acquir Immune Defic Syndr; 2001 May; 27(1):20-9. PubMed ID: 11404516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient patterns of care and longitudinal intensity of antiretroviral therapy for HIV-infected drug users.
    Laine C; Hauck WW; Turner BJ
    Med Care; 2002 Oct; 40(10):976-95. PubMed ID: 12395030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: relationship with outpatient care patterns.
    Laine C; Zhang D; Hauck WW; Turner BJ
    J Acquir Immune Defic Syndr; 2002 Mar; 29(3):270-4. PubMed ID: 11873076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients.
    McNaghten AD; Hanson DL; Dworkin MS; Jones JL;
    J Acquir Immune Defic Syndr; 2003 Apr; 32(5):499-505. PubMed ID: 12679701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients.
    d'Arminio Monforte A; Lepri AC; Rezza G; Pezzotti P; Antinori A; Phillips AN; Angarano G; Colangeli V; De Luca A; Ippolito G; Caggese L; Soscia F; Filice G; Gritti F; Narciso P; Tirelli U; Moroni M
    AIDS; 2000 Mar; 14(5):499-507. PubMed ID: 10780712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
    Patel N; Abdelsayed S; Veve M; Miller CD
    Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.
    Bassetti S; Battegay M; Furrer H; Rickenbach M; Flepp M; Kaiser L; Telenti A; Vernazza PL; Bernasconi E; Sudre P
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):114-9. PubMed ID: 10360802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
    Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F
    HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
    Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
    AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings.
    Venkatesh KK; Srikrishnan AK; Mayer KH; Kumarasamy N; Raminani S; Thamburaj E; Prasad L; Triche EW; Solomon S; Safren SA
    AIDS Patient Care STDS; 2010 Dec; 24(12):795-803. PubMed ID: 21091232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating clinical trial results into practice: the effect of an AIDS clinical trial on prescribed antiretroviral therapy for HIV-infected pregnant women.
    Turner BJ; Newschaffer CJ; Zhang D; Fanning T; Hauck WW
    Ann Intern Med; 1999 Jun; 130(12):979-86. PubMed ID: 10383368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women.
    Turner BJ; Newschaffer CJ; Zhang D; Cosler L; Hauck WW
    Med Care; 2000 Sep; 38(9):911-25. PubMed ID: 10982113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
    Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [First antiretroviral therapy regimen in HIV-infected patients. Durability and factors associated with therapy changes].
    de la Torre J; Santos J; Perea-Milla E; Pérez I; Moreno F; Palacios R; Santamaría S; Del Arco A; Nuño E; Godoy M; Prada JL; Olalla J; Aguilar J; Martos F;
    Enferm Infecc Microbiol Clin; 2008; 26(7):416-22. PubMed ID: 18842236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of antiretroviral use in the United States of America: analysis of three observational databases.
    Ghani AC; Donnelly CA; Anderson RM
    HIV Med; 2003 Jan; 4(1):24-32. PubMed ID: 12534956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nevirapine or efavirenz combined with two nucleoside reverse transcriptase inhibitors compared to HAART: a meta-analysis of randomized clinical trials.
    Torre D; Tambini R; Speranza F
    HIV Clin Trials; 2001; 2(2):113-21. PubMed ID: 11590519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.